U.S. FDA issues warning letter to Intas Pharma over manufacturing lapses
The U.S. FDA says the company's quality control unit failed to ensure its drug products meet specifications for "identity, strength, quality, and purity"
intas pharma
December 2023
August 2023
September 2022
US FDA flags ‘significant violations’ of CGMP norms at Gujarat-based Intas Pharma
The FDA asks the company to "correct any violations promptly", failing which the global agency may withhold approval of new applications or supplements listing
Covid catapults Cyrus Poonawalla to richest in pharma
Cyrus Soli Poonawalla’s Serum Institute of India made the most of the country’s demand for vaccines.
